[go: up one dir, main page]

WO2013175504A3 - Herbal composition for vaginal treatment - Google Patents

Herbal composition for vaginal treatment Download PDF

Info

Publication number
WO2013175504A3
WO2013175504A3 PCT/IN2013/000323 IN2013000323W WO2013175504A3 WO 2013175504 A3 WO2013175504 A3 WO 2013175504A3 IN 2013000323 W IN2013000323 W IN 2013000323W WO 2013175504 A3 WO2013175504 A3 WO 2013175504A3
Authority
WO
WIPO (PCT)
Prior art keywords
herbal composition
effective amount
vaginal treatment
plant extract
vaginal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2013/000323
Other languages
French (fr)
Other versions
WO2013175504A2 (en
Inventor
Rishi Bhatia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ULTRATECH INDIA Ltd
Original Assignee
ULTRATECH INDIA Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ULTRATECH INDIA Ltd filed Critical ULTRATECH INDIA Ltd
Priority to US14/401,582 priority Critical patent/US10201576B2/en
Publication of WO2013175504A2 publication Critical patent/WO2013175504A2/en
Publication of WO2013175504A3 publication Critical patent/WO2013175504A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses a herbal formulation comprising therapeutic effective amount of plant extract of Woodfordia Floribunda; therapeutic effective amount of plant extract of Centella Asiatica; and an effective amount of at least one pharmaceutically acceptable excipient.
PCT/IN2013/000323 2012-05-18 2013-05-20 Herbal composition for vaginal treatment Ceased WO2013175504A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/401,582 US10201576B2 (en) 2012-05-18 2013-05-20 Herbal composition for vaginal treatment

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1519MU2012 2012-05-18
IN1519/MUM/2012 2012-05-18

Publications (2)

Publication Number Publication Date
WO2013175504A2 WO2013175504A2 (en) 2013-11-28
WO2013175504A3 true WO2013175504A3 (en) 2014-01-16

Family

ID=49624459

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2013/000323 Ceased WO2013175504A2 (en) 2012-05-18 2013-05-20 Herbal composition for vaginal treatment

Country Status (2)

Country Link
US (1) US10201576B2 (en)
WO (1) WO2013175504A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106178140B (en) * 2016-07-29 2020-03-17 上海宇昂水性新材料科技股份有限公司 Pure natural water-soluble human body lubricant and preparation method and application thereof
WO2019035144A2 (en) * 2017-08-16 2019-02-21 Muniyal Ayurvedic Research Centre Composition for strengthening the immune system and method of preparation thereof
LT3773501T (en) * 2018-03-29 2024-01-10 The Materia Company Limited INTRAVAGINAL PREPARATION
EP3813944A1 (en) * 2018-06-29 2021-05-05 The Procter & Gamble Company Vaginal care compositions
CN108853471A (en) * 2018-07-11 2018-11-23 广州宜明生物化工有限公司 A kind of conditioning liquid and preparation method thereof for women koro
US10857151B1 (en) 2020-02-21 2020-12-08 Villya LLC Treatment of female genital schistosomiasis
US20220047506A1 (en) 2020-08-12 2022-02-17 Villya LLC Praziquantel Formulations
WO2024158694A1 (en) 2023-01-23 2024-08-02 Villya LLC Compositions and methods for improving the solubility of erectile dysfunction therapeutics

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010055625A1 (en) * 2000-03-28 2001-12-27 Katiyar Chandra Kant Herbal composition and method of manufacturing such composition for the management of gynecological disorders
US20030170326A1 (en) * 2001-12-13 2003-09-11 Council Of Scientific And Industrial Research Bioavailability enchancing activity of Zingiber officinale Linn and its extracts/fractions thereof
US20040022875A1 (en) * 2002-03-27 2004-02-05 Council Of Scientific & Industrial Research, Rafi Marg Anti peptic ulcer activity of an extract of a plant flower woodfordia fruticosa
US20070258913A1 (en) * 2004-09-17 2007-11-08 Bart Rossel Composition for Inhibiting or Preventing the Formation of a Biofilm
US20090035361A1 (en) * 2006-01-25 2009-02-05 Polichem S.A. Composition for vaginal use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766636A (en) * 1995-09-06 1998-06-16 Natura, Inc. Edible, low calorie compositions of a carrier and an active ingredient and methods for preparation thereof
DE19625560A1 (en) * 1996-06-26 1998-01-02 Edmund Ukleja Cosmetic products containing gold leaf flakes
CN101569414B (en) * 2008-04-29 2013-04-10 安琪酵母股份有限公司 Composition containing rich yeast selenium and yeast glucan
WO2009152389A2 (en) * 2008-06-11 2009-12-17 Katzenelson Omer Y Systems and methods to perform inhibition diagnostic testing

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010055625A1 (en) * 2000-03-28 2001-12-27 Katiyar Chandra Kant Herbal composition and method of manufacturing such composition for the management of gynecological disorders
US20030170326A1 (en) * 2001-12-13 2003-09-11 Council Of Scientific And Industrial Research Bioavailability enchancing activity of Zingiber officinale Linn and its extracts/fractions thereof
US20040022875A1 (en) * 2002-03-27 2004-02-05 Council Of Scientific & Industrial Research, Rafi Marg Anti peptic ulcer activity of an extract of a plant flower woodfordia fruticosa
US20070258913A1 (en) * 2004-09-17 2007-11-08 Bart Rossel Composition for Inhibiting or Preventing the Formation of a Biofilm
US20090035361A1 (en) * 2006-01-25 2009-02-05 Polichem S.A. Composition for vaginal use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
RANA ET AL.: "Herbal Remedies for Sexual Capability.", INDIAN JOURNAL OF TRADITIONAL KNOWLEDGE., vol. 11, no. 4, October 2012 (2012-10-01), pages 646 - 651 *

Also Published As

Publication number Publication date
US10201576B2 (en) 2019-02-12
WO2013175504A2 (en) 2013-11-28
US20150157674A1 (en) 2015-06-11

Similar Documents

Publication Publication Date Title
WO2013175504A3 (en) Herbal composition for vaginal treatment
MX370543B (en) Vegf neutralizing prodrugs for the treatment of ocular conditions.
IL235923A0 (en) Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof
IN2014MN02269A (en)
IL232764A (en) Fluoromethyl-5,6-dihydro-4h-[1,3]oxazines, pharmaceutical compositions comprising them and use thereof in the manufacture of medicaments for the treatment of alzheimer's disease
WO2013171764A3 (en) Ophthalmic formulations
HK1217650A1 (en) Compositions and methods for treating severe pain
KR102200014B9 (en) Composition for the prevention and treatment of menopausal symptoms comprising a soybean extract containing coumestrol as an active ingredient
WO2010028173A3 (en) Method of treating atrial fibrillation
WO2012091440A3 (en) Composition for improvement, treatment and prevention of gastrointestinal motility disorders
WO2013106068A3 (en) Therapeutic compositions of specified herbal formulations and uses thereof
WO2014107730A3 (en) Use of fatty acid niacin conjugates for treating diseases
WO2014121137A3 (en) Compositions and methods for the treatment of neurodegenerative and other diseases
WO2014153385A3 (en) Methods of treating metabolic disorders
EA036036B1 (en) Compositions comprising cyclosporin
EP3168214A4 (en) Substituted 2-thioxo-imidazolidin-4-ones and spiro analogues thereof, active anti-cancer ingredient, pharmaceutical composition, medicinal preparation, method for treating prostate cancer
WO2012131341A3 (en) Tight junctions modulators
WO2014102483A3 (en) Cosmetic or dermatological composition made of iris extracts and use thereof
EP3167893A4 (en) Pharmaceutical composition containing spirulina maxima extract as active ingredient for preventing and treating retinal diseases
WO2013177067A3 (en) Herbal composition for treatment of gastrointestinal inflammatory diseases and method to prepare and use thereof
MX364652B (en) Pharmaceutical formulation comprising ciclesonide.
WO2012019435A3 (en) Composition for treating neurodegenerative disease or neuropathological condition
CO6280404A2 (en) PROCESS OF OBTAINING A STANDARDIZED EXTRACT FROM A PLANT OF THE GENRE ALEURITES, EXTRACT OBTAINED AND PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH EXTRACT
NZ630125A (en) Herbal composition for the treatment of metabolic disorders
CA2863829A1 (en) Oral unit dosage forms and uses of same for the treatment of gaucher disease

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13794211

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
122 Ep: pct application non-entry in european phase

Ref document number: 13794211

Country of ref document: EP

Kind code of ref document: A2